RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

RUNX2 prompts triple negative breast cancer drug resistance through TGF-β pathway regulating breast cancer stem cells

Triple-negative breast cancer (TNBC) stands out as the most aggressive subtype within the spectrum of breast cancer. The current clinical guidelines propose treatment strategies involving cytotoxic agents like epirubicin or paclitaxel. However, the emergence of acquired resistance frequently precipi...

Полное описание

Библиографические подробности
Главные авторы:	Fengxu Lv, Wentao Si, Xiaodan Xu, Xiaogang He, Ying Wang, Yetian Li, Feifei Li
Формат:	Статья
Язык:	English
Опубликовано:	Elsevier 2024-02-01
Серии:	Neoplasia: An International Journal for Oncology Research
Предметы:	Triple negative breast cancer Chemoresistance Cancer stem cells RUNX2 TGF-β
Online-ссылка:	http://www.sciencedirect.com/science/article/pii/S1476558624000046

Схожие документы

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells via activating MMP1
по: Wentao Si, и др.
Опубликовано: (2022-11-01)

RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer
по: Natalia B. Fernández, и др.
Опубликовано: (2023-01-01)

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers
по: Bradley A. Hancock, и др.
Опубликовано: (2019-08-01)

Comprehensive Analysis of RUNX and TGF-β Mediated Regulation of Immune Cell Infiltration in Breast Cancer
по: Liang Gao, и др.
Опубликовано: (2021-08-01)

TGF-β induced reprogramming and drug resistance in triple-negative breast cells
по: Guoyu Wu, и др.
Опубликовано: (2022-04-01)

CIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
по: Alexander H. Chung, и др.
Опубликовано: (2019-02-01)

DNA methylation affects metastasis of renal cancer and is associated with TGF-β/RUNX3 inhibition
по: Jianbo Zheng, и др.
Опубликовано: (2018-04-01)

Atractylenolide-I Sensitizes Triple-Negative Breast Cancer Cells to Paclitaxel by Blocking CTGF Expression and Fibroblast Activation
по: Meng Wang, и др.
Опубликовано: (2021-10-01)

Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers
по: Anuradha Illendula, и др.
Опубликовано: (2016-06-01)

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model
по: Margarite D. Matossian, и др.
Опубликовано: (2019-03-01)

Data mining analysis of miR-638 and key genes interaction in cisplatin resistant triple-negative breast cancer
по: Adam Hermawan, и др.
Опубликовано: (2019-12-01)

The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context
по: Adiba S. Khan, и др.
Опубликовано: (2023-02-01)

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
по: Shen-Jun Yuan, и др.
Опубликовано: (2019-10-01)

B7-H4 overexpression contributes to poor prognosis and drug-resistance in triple-negative breast cancer
по: Ling Wang, и др.
Опубликовано: (2018-07-01)

A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
по: Hitesh Kumar, и др.
Опубликовано: (2023-12-01)

miR-613 Suppresses Chemoresistance and Stemness in Triple-Negative Breast Cancer by Targeting FAM83A
по: Liu C, и др.
Опубликовано: (2020-12-01)

A clinicopathologic study of triple negative breast cancer
по: Vandana L Gaopande, и др.
Опубликовано: (2015-01-01)

IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
по: Nicholas R. Hum, и др.
Опубликовано: (2022-07-01)

Clinically Translatable Approaches of Inhibiting TGF-β to Target Cancer Stem Cells in TNBC
по: Andrew Sulaiman, и др.
Опубликовано: (2021-10-01)

CXCR2 Small-Molecule Antagonist Combats Chemoresistance and Enhances Immunotherapy in Triple-Negative Breast Cancer
по: Alaa M. Ghallab, и др.
Опубликовано: (2022-04-01)

Discovery of a natural small-molecule compound that suppresses tumor EMT, stemness and metastasis by inhibiting TGFβ/BMP signaling in triple-negative breast cancer
по: Lei Di, и др.
Опубликовано: (2019-03-01)

TUFT1 promotes metastasis and chemoresistance in triple negative breast cancer through the TUFT1/Rab5/Rac1 pathway
по: Weiguang Liu, и др.
Опубликовано: (2019-09-01)

RUNX regulated immune-associated genes predicts prognosis in breast cancer
по: Jingyue Fu, и др.
Опубликовано: (2022-08-01)

M6A demethylase ALKBH5 regulates FOXO1 mRNA stability and chemoresistance in triple-negative breast cancer
по: Xi Liu, и др.
Опубликовано: (2024-02-01)

CD74-AKT Axis Is a Potential Therapeutic Target in Triple-Negative Breast Cancer
по: Jingchao Wang, и др.
Опубликовано: (2024-06-01)

Role of eIF4A1 in triple‐negative breast cancer stem‐like cell‐mediated drug resistance
по: Dayanidhi Raman, и др.
Опубликовано: (2022-12-01)

Cyclodextrin Diethyldithiocarbamate Copper II Inclusion Complexes: A Promising Chemotherapeutic Delivery System against Chemoresistant Triple Negative Breast Cancer Cell Lines
по: Ammar Said Suliman, и др.
Опубликовано: (2021-01-01)

Kinome-Wide siRNA Screening Identifies Src-Enhanced Resistance of Chemotherapeutic Drugs in Triple-Negative Breast Cancer Cells
по: Yen-Dun Tony Tzeng, и др.
Опубликовано: (2018-11-01)

TUFT1 Promotes Triple Negative Breast Cancer Metastasis, Stemness, and Chemoresistance by Up-Regulating the Rac1/β-Catenin Pathway
по: Weiguang Liu, и др.
Опубликовано: (2019-07-01)

Current approaches in treatment of triple-negative breast cancer
по: Hanan Ahmed Wahba, и др.
Опубликовано: (2015-06-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
по: Mahdi Aghili, и др.
Опубликовано: (2013-08-01)

Platinum chemotherapy for early triple-negative breast cancer
по: Sofia RE. Mason, и др.
Опубликовано: (2024-06-01)

Does triple negative breast cancer subtype carry poorer prognosis as compared to non-triple negative breast cancer lesion - A study from a tertiary hospital
по: Srijan Basu, и др.
Опубликовано: (2023-11-01)

Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
по: Omran Saifi, и др.
Опубликовано: (2022-04-01)

USP7 Induces Chemoresistance in Triple-Negative Breast Cancer via Deubiquitination and Stabilization of ABCB1
по: Yueh-Te Lin, и др.
Опубликовано: (2022-10-01)

Immunotherapy Treatment for Triple Negative Breast Cancer
по: Elizabeth R. Berger, и др.
Опубликовано: (2021-08-01)

Immunohistochemical evaluation of osteopontin expression in triple-negative breast cancer
по: Magdalena Niedolistek, и др.
Опубликовано: (2020-04-01)

Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer Cells
по: Lisa Agnello, и др.
Опубликовано: (2023-07-01)

Metastatic Triple Negative Breast Cancer: The New Era of Thinking
по: Mohammed Amrallah A., и др.
Опубликовано: (2021-05-01)

The Adipokine Visfatin Modulates Cancer Stem Cell Properties in Triple-Negative Breast Cancer
по: Yi-Fen Chiang, и др.
Опубликовано: (2023-01-01)